Medications studied for discontinuation.

Buprenorphine

A partial μ-opioid agonist used as first-line medication-assisted treatment (MAT) for opioid use disorder. Multiple case reports and case series describe successful transition from kratom or concentrated kratom-alkaloid dependence to buprenorphine maintenance, followed by gradual taper. Standard induction protocols developed for traditional-opioid OUD apply with adjustments for kratom-specific receptor profile [5]. Buprenorphine is FDA-approved and widely prescribed; a clinician can search the SAMHSA Buprenorphine Practitioner Locator for an authorized prescriber.

Methadone

A full μ-opioid agonist used in opioid treatment programs (OTPs). Less commonly used for kratom-related OUD than buprenorphine due to higher administrative burden (daily clinic dosing) but appropriate in some clinical contexts. Strong evidence base for OUD overall.

Naltrexone

A μ-opioid antagonist available as an oral tablet or extended-release injection (Vivitrol). Useful for relapse prevention after detox is complete, but must not be administered to actively-using or recently-using patients (precipitates immediate severe withdrawal). Limited but positive evidence in kratom OUD case reports.

Lofexidine and clonidine

α2-adrenergic agonists. Reduce autonomic withdrawal symptoms (sweating, GI distress, restlessness, anxiety) without acting at opioid receptors. Used during detox as adjuncts. Clonidine is older, cheaper, off-label for this use; lofexidine (Lucemyra) is FDA-approved for opioid withdrawal symptom management. Both reduce symptom burden but don't address craving or post-acute withdrawal.

Other adjuncts

• Gabapentinoids (gabapentin, pregabalin) — used for restless-leg-type symptoms during acute withdrawal. Caution: dependence and respiratory-depression risk with concurrent opioids.
• Antiemetics — ondansetron, promethazine for nausea/vomiting during detox.
• Antidepressants/anxiolytics — for protracted dysphoria, depression, anxiety. Standard PCP/psychiatric prescribing applies.
• Behavioral therapy — CBT, motivational interviewing, contingency management. Adds substantial relapse-prevention value alongside medication.

What about "at-home" approaches?

Kratom-recovery communities discuss approaches ranging from over-the-counter supplements (kava, magnesium, melatonin for sleep) to harm-reduction substitution with milder kratom strains or low-dose 7-OH-stop products like SR-17018. The published evidence for these approaches is anecdotal at best. We don't take a position on community protocols; we link to the resources without endorsing them. See /Resources for peer communities including r/QuittingKratom.

This page is not treatment advice

The medications above all require a prescription and clinical assessment. A clinician will choose, dose, and monitor what fits your situation. The SAMHSA Helpline can connect you to a same-week clinician evaluation: 1-800-662-HELP.

References

See our bibliography.